While Open Access is helping mission-driven publishing societies to disseminate knowledge, it is also causing them to re-evaluate their financial business models.
On Tuesday, October 21, Deni Auclair, Vice President & Lead Analyst, Outsell Inc.; Esmeralda Galán Buchanan, Journals Director, American Cancer Society; Rachel Burley, Vice President & Director of Open Access, John Wiley & Sons; Philip Wright, Chief Executive, The Physiological Society offered an audience of society publishers and editorial staff their “real world” case studies for launching successful Open Access journals. The program was co-sponsored by CCC and Wiley. With CCC’s Chris Kenneally moderating, the panel shared insights, challenges and solutions for Open Access across a spectrum of society publishing programs.
- Deni Auclair joined Outsell, Inc., the only research and advisory firm focused on the information industry, in November of 2013 as VP & Lead Analyst covering the Science, Technology, Medical & Healthcare segment. Prior to joining Outsell, she was President of Media Growth Strategies, LLC (MGS), a consulting firm serving publishing and its affiliated industries. She was previously VP, Corporate Development at John Wiley & Sons, Inc., and served as CFO at the Journal of Bone & Joint Surgery.
- As Vice President and Director, Open Access for Wiley, Rachel Burley has responsibility for Wiley’s open access publishing activities, leading a team dedicated to expanding open access. Wiley now publish 30 open access journals with 20 more launching in 2014. Wiley’s hybrid option has also been expanded to 1,257 journal, 82% of Wiley’s journals program. Rachel and her colleagues work closely with Wiley’s Society partners to expand the high quality, open access publishing options available to the communities they serve. Originally from the UK, Rachel now lives in New York and is based in Wiley’s Hoboken offices.
- Esmeralda Galán Buchanan has been with the American Cancer Society for almost 15 years and currently serves as the Journals Director for the journals publishing program where she oversees the editorial and business operations for the journals Cancer, CancerCytopathology, and CA: A Cancer Journal for Clinicians. She is also responsible for the ACS’s Continuing Education program and related journal-based activities.
- Currently Chief Executive of The Physiological Society, Philip J. Wright has extensive experience of the pharmaceutical, biological and biomedical science sectors. In 2007 he founded and led as Chief Executive, Stem Cells for Safer Medicines Ltd (SC4SM) a public-private research collaboration to develop the use of stem cells in early drug safety screening. From 2002 to 2009 he was Director of Science and Technology at the Association of the British Pharmaceutical Industry (ABPI) leading a number of other high profile initiatives to support R&D. Previously he was Director of Scientific & Educational Affairs at Glaxo Wellcome. He holds a Ph.D. in Marine Biology.